Serotonin (5‐HT) induces concentration‐dependent metabolic effects in diverse cell types,
including neurons, entherochromaffin cells, adipocytes, pancreatic beta‐cells, fibroblasts …

Background Treatment for chronic hepatitis C (CH‐C) is rapidly changing and moving away
from an interferon and ribavirin‐based therapy to interferon‐free ribavirin‐free all oral …

Anhedonia, characterized by a loss of interest and/or pleasure in previously enjoyable
activities, is an important diagnostic criterion of Major Depressive Disorder (MDD) …

The precise neural mechanisms underlying the pathogenesis of depression are largely
unknown, though stress-induced brain inflammation and serotonergic plasticity are thought …

Objective Direct acting antivirals (DAAs) have overcome many long-standing medical
barriers to hepatitis C virus (HCV) treatment (ie host characteristics and medical …

More than 20% of chronic hepatitis C (CHC) patients receiving interferon-alpha (IFN-α)-
based anti-hepatitis C virus (HCV) therapy experienced significant depression, which was …

Purpose–The purpose of this paper is to provide a comprehensive overview of the current
knowledge regarding chronic hepatitis C (CHC) infection, antiviral therapy, depression, and …

Hepatitis C virus (HCV) infection is a leading cause of liver disease and liver-related deaths
among those living with human immunodeficiency virus (HIV) infection. Due to recent …

Background and aims: Exercise is an effective therapy for major depressive disorder (MDD)
and has been demonstrated to have anti-inflammatory effects in non depressed subjects. In …

Affective (mood) disorders are leading causes of functional disability worldwide. From a
domain-based approach, treatment outcomes of major depressive disorder (MDD) are …